Mira Pharmaceuticals Inc. Logo

Mira Pharmaceuticals Inc. (MIRA)

NASDAQ

Currency in USD
0.7753
-0.01 (-1.61%)

Closed

Aug 25, 2026

Day's Range

0.7683
0.8100

52 wk Range

0.6000
2.45

Profile - MIRA - Mira Pharmaceuticals Inc.

Profile

Mic Code

XNCM

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

0


Mira Pharmaceuticals Inc. operates in the biotechnology industry, focusing on the research and development of novel therapeutics. The company is dedicated to advancing pharmaceuticals that address unmet medical needs, primarily targeting neurological and neuropsychiatric disorders. Through innovative drug development processes, Mira Pharmaceuticals aims to improve quality of life for patients suffering from conditions such as anxiety, depression, and cognitive impairments. This approach involves sophisticated technologies for drug formulation and delivery, ensuring efficient and effective treatment options. The company’s role in the financial market centers around its potential to introduce groundbreaking drugs, drawing attention from investors, healthcare professionals, and regulatory bodies. By addressing significant healthcare challenges, Mira Pharmaceuticals not only contributes to scientific progress but also plays a crucial part in the healthcare industry, impacting portfolios that focus on cutting-edge medical innovations and pharmaceutical advancements.

Profile Details

Type

Common Stock

Ceo

Mr. Erez Aminov

Address

1200 Brickell Avenue

City

Miami

State

FL

Zip

32183

Country

United States

Phone

786-432-9792

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.